FDA Inspection 1154980 — Medtronic Spinal And Biologics New York Distribution Center

Medtronic Spinal And Biologics New York Distribution Center — FEI 3007026906

The FDA completed an inspection of Medtronic Spinal And Biologics New York Distribution Center on Aug 18, 2021 in Swedesboro, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Aug 18, 2021
Fiscal Year
2021
Product Type
Devices
Project Area
Compliance: Devices
Location
Swedesboro, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.